Network analysis identifies strain-dependent response to tau and tau seeding-associated genes
Open accessPublished version of a preprint
Abstract
Previous research demonstrated that genetic heterogeneity is a critical factor in modeling amyloid accumulation and other Alzheimer’s disease phenotypes. However, it is unknown what mechanisms underlie these effects of genetic background on modeling tau aggregate-driven pathogenicity. In this study, we induced tau aggregation in wild-derived mice by expressing MAPT. To investigate the effect of genetic background on the action of tau aggregates, we performed RNA sequencing with brains of C57BL/6J, CAST/EiJ, PWK/PhJ, and WSB/EiJ mice (n = 64) and determined core transcriptional signature conserved in all genetic backgrounds and signature unique to wild-derived backgrounds. By measuring tau seeding activity using the cortex, we identified 19 key genes associated with tau seeding and amyloid response. Interestingly, microglial pathways were strongly associated with tau seeding activity in CAST/EiJ and PWK/PhJ backgrounds. Collectively, our study demonstrates that mouse genetic context affects tau-mediated alteration of transcriptome and tau seeding. The gene modules associated with tau seeding provide an important resource to better model tauopathy.
AI snapshot
Written from the paper’s full text.
TL;DR
This study expressed AAV-hTauP301L in C57BL/6J and three wild-derived mouse strains to test how genetic background affects tau seeding and cortical transcriptomes. CAST and PWK showed increased tau seeding independent of tau expression, and network analysis implicated a 666-gene microglial/innate-immune module as a putative mediator.
Key findings
- Tau seeding activity was significantly affected by genetic background (one-way ANOVA: F3,78 = 9.237, P = 2.67 × 10−5), with elevated seeding in CAST and PWK relative to B6 (*P < 0.001; B6-CAST p_adj = 0.046, B6-PWK p_adj = 1.12 × 10−4), but no significant B6 vs WSB difference. This was independent of human tau expression: no genetic-background effect on hMAPT mRNA (F3,66 = 0.234, P = 0.87), total tau (F3,75 = 1.439, P = 0.238), or pTau231 (F3,75 = 1.665, P = 0.189).
- Bulk RNA-seq identified a core tau-responsive Signature A of 2,467 DEGs shared across all genetic backgrounds, out of total DEGs of 4,784 in B6, 5,260 in CAST, 4,657 in PWK, and 4,958 in WSB. Signature A was enriched for neurodegeneration pathways, including 168 of 471 genes in KEGG map05022 “Pathways of neurodegeneration—multiple diseases.”
- Signature B comprised 133 DEGs in one or more wild-derived backgrounds, with 17 shared by CAST, PWK, and WSB; there were 53 CAST-specific, 22 PWK-specific, and 25 WSB-specific DEGs. These were not large enough to reach significance in enrichment analyses, but the 133 genes were enriched for pathways such as asthma and Staphylococcus aureus infection.
- WGCNA identified 60 modules, 21 significantly associated with seeding activity or wild-derived genetic background. The darkorange module (Signature C) contained 666 genes, was positively correlated with FRET seeding (R2 = 0.54, P = 7 × 10−6) and wild-derived background (R2 = 0.27, P = 0.03), and was a significant mediator by HIMA (P = 0.0349), most likely via complete mediation; it was enriched for microglia-related terms, with 21 homeostatic and 18 disease-associated microglial marker genes.
Methods
- Mice from C57BL/6J, CAST/EiJ, PWK/PhJ, and WSB/EiJ backgrounds received intracerebroventricular AAV9-CBA/CMV-hTauP301L or AAV-eGFP at postnatal day 0 and were harvested at 6 mo; final sample sizes were B6 = 20, CAST = 20, PWK = 19, WSB = 24. Genotyping used the gigaMUGA platform with 143,259 markers, and variants were filtered against AMP-AD nominated target genes.
- Tau seeding was measured with HEK-293T TauRD P301S FRET biosensor cells transfected with TBS-soluble cortical lysate, with FRET+ signal measured by FACS. Tau expression/pathology was assessed by qPCR, Meso Scale Diagnostics for total tau and pTau231, histology, and Western blotting.
- Bulk mRNA-seq was performed on cortex (n = 8/background/AAV injection group; 32/AAV group), with DESeq2 for per-strain and interaction-model DEG analyses and WGCNA for co-expression modules. Mediation was tested with HIMA and bmediatR, and targeted validation used the nCounter mouse neuroinflammation panel (n = 3/genotype/injection, females).
Limitations
- Stated: microglial transcriptional state was inferred from bulk transcriptomic data, and single-cell RNA-seq will be necessary to determine which microglial cell types are involved. Future experiments are needed to test functional effects of candidate genes by knockdown one by one, in combination, and in a cell-type-specific manner.
- Stated: more research is necessary to understand which tau species contribute to the increased seeding activity in wild-derived cortex. Genotyping was limited to variants captured by the selected Illumina Infinium platform.
- Stated/evident: WGCNA did not reach the recommended scale-free topology fit cutoff of 0.9, and a soft power threshold of 6 was selected based on package recommendations for datasets with more than 40 samples. The cross-study meta-analysis could not match sex, exact brain region, promoter, or genetic background.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
44 of 48 cited sources checked · 28 supported · 1 flagged · accuracy not yet measured
- Premisecitation
Mice with APPswe and PSEN1de9 transgenes backcrossed onto wild-derived backgrounds had higher levels of amyloid-β compared with age-matched mice on a B6 background.
“These mice had higher levels of amyloid-β (Aβ) compared with age-matched mice on a B6 background (Onos et al., 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Onos et al., 2019 source
The Results section, “Evidence of mixed pathologies in wild-derived APP/PS1 strains,” reports higher Aβ42 levels than in B6.APP/PS1 mice for female CAST.APP/PS1 and WSB.APP/PS1 mice at 8 months. It does not establish higher Aβ levels for all wild-derived backgrounds or for males; it also reports fewer cortical plaques in all three wild-derived strains. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
Responses of homeostatic microglia and disease-associated microglia are determined by wild-derived genetic backgrounds.
“Single-cell RNA sequencing (RNA-seq) of sorted microglia further demonstrated that the responses of immune cell subtypes, namely homeostatic microglia and disease-associated microglia (DAMs), are determined by wild-derived genetic backgrounds (Yang et al., 2021).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Yang et al., 2021 source
- Findingown data
Neurodegenerative hub-genes were detected by comparing Signature C (darkorange) and wild-derived amyloid response (Fisher's exact test: P = 1.62 × 10−19).
“Neurodegenerative hub-genes (purple) were detected by comparing Signature C (darkorange) and wild-derived amyloid response (Fisher’s exact test: P = 1.62 × 10−19; Onos et al., 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Onos et al., 2019 source
- Findingown data
In comparison to the 35-gene module from Onos et al., 19 of their genes were significantly enriched also in the darkorange module (Fisher exact test, P = 1.62 × 10−19).
“In comparison to their 35-gene module, we found that 19 of their genes were significantly enriched also in our darkorange module (Fig. 6 C, highlighted in purple; Fisher exact test, P = 1.62 × 10−19).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Onos et al., 2019 source
- Findingown data
Trem2 is present in Signatures A and C.
“For example, Trem2, a known AD risk gene expressed in microglia (Krasemann et al., 2017; Sims et al., 2017), is present in Signatures A and C.”
Quote in the paperNot a substantial claim2 of 2 sources checked
- Findingcitation
The output of the mouse neurological disorders RNA-seq portal showed a downregulation of Signature C genes within studies designated "other cell types".
“Notably, the output of this portal showed a downregulation of Signature C genes within studies designated “other cell types” (Fig. S5 C).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Al-Ouran et al., 2019 source
The Results and Discussion section describes this portal and shows downregulated genes in mouse models studying different cell types. Those results concern the paper’s yellow-module gene set, however; our copy does not report an analysis of Signature C genes or a category designated “other cell types.” (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Interpretationreasoning
Our list of core genes can be interpreted as robust tau-responsive genes for future study.
“As preclinical studies continue to make direct comparisons between human and mouse transcriptomics (Monzón-Sandoval et al., 2022; Onos et al., 2022), our list of core genes can be interpreted as robust tau-responsive genes for future study.”
Quote in the paperNot a substantial claim2 of 2 sources checked - Premisecitation
A similar effect of genetic background was found via WGCNA when modeling Aβ.
“A similar effect of the genetic background was found via WGCNA when modeling Aβ (Onos et al., 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Onos et al., 2019 source
- Premisecitation
Transcriptomic data from Onos and colleagues showed a compelling effect of these three wild-derived strains on amyloid accumulation.
“Transcriptomic data from Onos and colleagues showed a compelling effect of these three wild-derived strains on amyloid accumulation (Onos et al., 2019; Yang et al., 2021).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Onos et al., 2019 source
The Results section on mixed pathologies reports significantly fewer cortical plaques in all three wild-derived APP/PS1 strains than in B6.APP/PS1, establishing strain differences in amyloid deposition. The transcriptional-profiling Results instead show strain-dependent gene expression and responses to amyloid; they do not themselves establish an effect on amyloid accumulation. Page numbers are not available in the supplied copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Yang et al., 2021 source
The Introduction and Results report transcriptomic differences among the wild-derived strains in microglial responses to amyloid. The Results also report higher cerebral amyloid angiopathy in WSB.APP/PS1, but the cited paper does not show that its transcriptomic data establish an effect of all three strains on amyloid accumulation. Page numbers were not supplied in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingown data
Using the expression of 11 mouse orthologs of human AD GWAS loci genes, wild-derived mice are transcriptionally distinct from B6 mice regardless of tau genotype.
“Using the expression of these 11 genes, wild-derived mice are transcriptionally distinct from B6 mice regardless of tau genotype (Fig. S5 B).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Salih et al., 2019 source
The Results section (“High-resolution co-expression network using RNA-seq in amyloid-responsive microglia”; page unavailable) identifies 11 mouse orthologues of human Alzheimer’s disease GWAS loci. It does not report that their expression distinguishes wild-derived mice from B6 mice, with or without a tau genotype; its comparisons concern APP/PSEN1 mice and wild-type controls. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Findingcitation
There is a considerable overlap when comparing the tau seeding-associated genes in wild-derived mouse strains to a previous study of amyloid response in wild-derived strains.
“Interestingly, we see a considerable overlap when comparing the tau seeding–associated genes in wild-derived mouse strains to a previous study of amyloid response in wild-derived strains (Onos et al., 2019).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Onos et al., 2019 source
- Findingown data
The gene lists can be used with external databases like the mouse neurological disorders RNA-seq portal to probe similar signatures across mouse models.
“We demonstrated the ability to use our gene lists with external databases like the mouse neurological disorders RNA-seq portal (Al-Ouran et al., 2019) to probe similar signatures across mouse models.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Al-Ouran et al., 2019 source
- Findingown data
Principal component analysis demonstrates that the largest contribution to transcriptome variation is genetic background.
“Principal component analysis (PCA) demonstrates that the largest contribution to the variation in the transcriptome is genetic background (Fig. 3 B).”
Quote in the paperSubstantial claim - Findingown data
Four modules were significantly correlated to both seeding activity and wild-derived genetic background: darkorange, steelblue, lightsteelblue1, and sienna3.
“Using this approach, we were able to identify four modules that were significantly correlated to both traits of interest: darkorange, steelblue, lightsteelblue1, and sienna3 (Fig. 5 A).”
Quote in the paperSubstantial claim - Findingown data
Across all three wild-derived mice, genotyped variants were found in 401 of the 537 nominated target genes.
“Across all three wild-derived mice in this study, we found genotyped variants in 401 of the total 537 nominated target genes.”
Quote in the paperSubstantial claim - Findingown data
Representative samples demonstrate the presence of high molecular weight and low molecular weight species of phospho-tau Thr231 and total tau.
“Representative samples demonstrate the presence of high molecular weight and low molecular weight species of phospho-tau Thr231 and total tau (DAKO).”
Quote in the paperNot a substantial claim - Findingown data
Human MAPT mRNA levels showed no significant effect of genetic background (F3,66 = 0.234, P = 0.87).
“Relative hMAPT expression was calculated relative to GAPDH and showed no effect of genetic background via one-way ANOVA (n = 16–20 per group, technical replicates = 2, F3,66 = 0.234, P = 0.87).”
Quote in the paperSubstantial claim - Findingown data
17 out of 133 DEGs in Signature B were shared by all three wild-derived backgrounds.
“17/133 DEGs in Signature B were shared by all three wild-derived backgrounds.”
Quote in the paperSubstantial claim - Findingown data
168 genes out of the 471 genes in the KEGG pathway 'Pathways of neurodegeneration-multiple diseases' (map05022) follow the genetic background-independent effect.
“A total of 168 genes out of the 471 genes in the pathway (Pathways of neurodegeneration—multiple diseases KEGG map05022) follow this genetic background–independent effect (Fig. S3 F).”
Quote in the paperSubstantial claim - Findingown data
There was no effect of genetic background on pTau231 levels (F3,75 = 1.665, P = 0.189).
“or pTau231 (n= 19–21 per group, F3,75 = 1.665, P = 0.189).”
Quote in the paperSubstantial claim - Findingown data
There was no significant difference in tau seeding activity between B6 and WSB AAV-hTauP301L-injected mice (P > 0.05).
“However, there was no significant difference between B6 and WSB AAV-hTauP301L–injected mice (P > 0.05).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.
- Findingown data
Ube2j1, Calm3, and Mapk1 genes were lowly expressed similarly in B6 and all three wild-derived mice injected with AAV-hTauP301L compared with AAV-eGFP-injected controls.
“For example, Ube2j1, Calm3, and Mapk1 genes were lowly expressed similarly in B6 and all three wild-derived mice injected with AAV-hTauP301L compared with the AAV-eGFP–injected control group (Fig. 3 E).”
Quote in the paperNot a substantial claim - Findingown data
2,467 genes were commonly expressed across all genetic backgrounds and were identified as DEGs in all genetic backgrounds.
“Of these DEGs, 2,467 genes were commonly expressed across all genetic backgrounds and were identified as DEGs in all genetic backgrounds (yellow highlighted intersection, Fig. 3 C).”
Quote in the paperSubstantial claim - Findingown data
60 modules of co-expressed genes were identified by WGCNA.
“We identified 60 modules of co-expressed genes (Table S1 I and Fig S4, A–C)”
Quote in the paperSubstantial claim - Findingown data
There was no effect of genetic background on total tau levels (F3,75 = 1.439, P = 0.238).
“There was no effect of genetic background on either total tau via one-way ANOVA (n = 19–21 per group, F3,75 = 1.439, P = 0.238)”
Quote in the paperSubstantial claim - Findingown data
Genes within the darkorange module were most positively correlated to tau seeding.
“Gene significance calculation of each gene in the four modules of interest reveals the genes within the darkorange module were most positively correlated to tau seeding (Fig. 5 B).”
Quote in the paperSubstantial claim- The authors state this as an assumption: FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.
- Findingown data
17 genes were shared by CAST, PWK, and WSB that were not differentially expressed in B6 mice.
“There were 17 genes shared by CAST, PWK, and WSB (Fig. 4 B) that were not differentially expressed in B6 mice.”
Quote in the paperSubstantial claim - Findingown data
Tau seeding activity was significantly affected by genetic background (F3,78 = 9.237, P = 2.67 × 10−5).
“Tau seeding activity was significantly affected by genetic backgrounds via one-way ANOVA (n = 19–24 per group, technical replicates =2, F3,78 = 9.237, P = 2.67 × 10−5).”
Quote in the paperSubstantial claim- The authors state this as an assumption: FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.
- Findingown data
A total number of 79 DEGs were identified in CAST, 51 in PWK, and 53 in WSB using genetic background as a covariate.
“A total number of 79 DEGs were identified in CAST (Effect: tau.CAST; Table S1 F), 51 DEGs in PWK (Effect: tau.PWK; Table S1 G), and 53 DEGs in WSB (Effect: tau.WSB; Table S1 H).”
Quote in the paperSubstantial claim - Findingown data
Cilia- and flagella-associated protein 74 was upregulated in wild-derived mice injected with AAV-hTauP301L compared with AAV-GFP-injected mice of the same genetic background.
“As an example, cilia- and flagella-associated protein 74 was upregulated in wild-derived mice injected with AAV-hTauP301L compared with AAV-GFP–injected mice of the same genetic background (Fig. 4 C).”
Quote in the paperNot a substantial claim - Findingown data
136 of the 537 AMP-AD target genes did not contain any genotyped variants.
“136 of the 537 AMP-AD target genes did not contain any genotyped variants.”
Quote in the paperNot a substantial claim - Findingown data
The 133 genes in Signature B are enriched for several pathways that have not been studied well in the context of tauopathy.
“taken together, these 133 genes in Signature B are enriched for several pathways that have not been studied well in the context of tauopathy (Table S2 K).”
Quote in the paperNot a substantial claim - Findingown data
Percent cells with FRET signal were significantly increased in WSB versus B6 in the pilot study (P = 0.0172).
“Percent cells with FRET signal were significantly increased in WSB versus B6 in our pilot study (*P < 0.05; nB6 = 6, nWSB = 5; Welch’s t test P = 0.0172).”
Quote in the paperSubstantial claim - Findingown data
In total, 5,792 variants were found in 537 AMP-AD nominated target genes.
“In total, we found 5,792 variants in 537 nominated target genes (Table S1, A and B).”
Quote in the paperNot a substantial claim - Findingown data
133 DEGs were identified in one or more wild-derived backgrounds.
“133 in total DEGs were identified in one or more wild-derived backgrounds.”
Quote in the paperSubstantial claim - Findingown data
KEGG enrichment analysis of the 2,467-gene Signature A was significantly enriched for several neurodegenerative terms.
“Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of this gene set (2,467 genes) was significantly enriched for several neurodegenerative terms (Fig. 3 D, Fig. S3 E, and Table S2 J).”
Quote in the paperSubstantial claim - Findingown data
CAST and PWK genetic background mice had significantly elevated tau seeding activity compared to B6 controls (P < 0.001).
“Tukey honest significant difference post-hoc test revealed elevated tau seeding activity in CAST and PWK relative to B6 (***P < 0.001; B6-CAST p_adj = 0.046, B6-PWK p_adj = 1.12 × 10−4).”
Quote in the paperSubstantial claim- The authors state this as an assumption: FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.
- Findingown data
Of the 60 modules, 21 were significantly associated with either seeding activity or wild-derived genetic background (P < 0.05).
“Of these 60 modules, 21 were significantly associated with either seeding activity or wild-derived genetic background (Fig. S4 D, P < 0.05).”
Quote in the paperSubstantial claim - Findingown data
None of these 21 modules demonstrated a significant effect of sex.
“Importantly, none of these 21 modules demonstrated a significant effect of sex (Fig. S4 D).”
Quote in the paperNot a substantial claim - Findingown data
The majority of darkorange module genes on the mouse neuroinflammation panel were annotated as part of the Innate Immune Response and/or Microglia Function (29 out of 56).
“The majority of darkorange module genes on the mouse neuroinflammation panel were annotated as being a part of the Innate Immune Response and/or Microglia Function (29 out of 56; Fig. 8 B and Table S2 R).”
Quote in the paperSubstantial claim - Findingown data
The core transcriptional response to tau across different genetic backgrounds is enriched for pathways of neurodegeneration.
“Importantly, our study shows that the core transcriptional response to tau across different genetic backgrounds is enriched for pathways of neurodegeneration (Fig. 3).”
Quote in the paperSubstantial claim - Findingown data
The darkorange module contains 666 genes associated with the effect of genetic background on tau seeding activity.
“The darkorange module contains a total of 666 genes that we found to be associated with the effect of genetic background on tau seeding activity (Fig. 6 C, highlighted in orange).”
Quote in the paperSubstantial claim - Findingown data
Analysis of publicly available data collected from mouse models of tauopathy reveals a modest overlap between our AAV approach and similar tau models at 6 mo.
“Analysis of publicly available data collected from mouse models of tauopathy (GSE114910, GSE125957) reveals a modest overlap between our AAV approach and similar tau models at 6 mo.”
Quote in the paperNot a substantial claim - Findingown data
The Microglia Function pathway was decreased in both PWK and CAST mice.
“The “Innate Immune Response” pathway was concordantly increased in PWK and CAST mice, while the “Microglia Function” pathway was decreased in both genetic backgrounds.”
Quote in the paperSubstantial claim - Findingown data
Bayesian module selection found that the darkorange module is most likely to act through complete mediation between genetic background, seeding activity, and the darkorange module.
“Of these three possible relationships between genetic background, seeding activity, and the darkorange as a mediator, we found that the darkorange module is most likely to act through complete mediation.”
Quote in the paperSubstantial claim - Findingown data
There is a clear shift in homeostatic and disease-associated marker genes across the genetic background when hTauP301L is expressed.
“Although we are inferring the microglial transcriptional state from bulk transcriptomic data, there is a clear shift in homeostatic and disease-associated marker genes across the genetic background when hTauP301L is expressed.”
Quote in the paperSubstantial claim - Findingown data
There are 18 disease-associated marker genes within the darkorange module (Fisher's exact test: P = 2.31 × 10−5).
“We found 21 homeostatic marker genes (Fisher’s exact test: P = 2.33 × 10−7) and 18 disease-associated marker genes (Fisher’s exact test: P = 2.31 × 10−5) within the darkorange module.”
Quote in the paperSubstantial claim - Findingown data
Approximately 8% (56/666) of the genes in the darkorange module were selected as part of the mouse neuroinflammation panel curated list.
“We found that ∼8% (56/666) of the genes in the darkorange module were selected as part of this curated list (Table S2 R).”
Quote in the paperSubstantial claim - Findingown data
28 out of 56 darkorange module genes on the mouse neuroinflammation panel were significantly upregulated in AAV-hTauP301L-injected mice versus AAV-eGFP-injected controls across all genetic backgrounds.
“We found that 28 out of 56 darkorange module genes on the mouse neuroinflammation panel were significantly upregulated in AAV-hTauP301L–injected mice versus AAV-eGFP–injected controls across all genetic backgrounds, validating the involvement of these darkorange module genes in the immune response to tau (Fig. 7, A–D).”
Quote in the paperSubstantial claim - Findingown data
Bayesian model selection suggests that the relationship between the darkorange module and tau seeding is most probabilistically via complete mediation.
“Furthermore, Bayesian model selection suggests that the relationship between the darkorange module and tau seeding is most probabilistically via complete mediation (dark green arrows).”
Quote in the paperSubstantial claim- The authors state this as an assumption: FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.
- Findingown data
Of the 28 shared upregulated genes, the highest fold change was observed in CAST and PWK mice.
“Of these 28 genes, the highest fold change was observed in CAST and PWK mice (Fig. 7 E).”
Quote in the paperSubstantial claim - Findingown data
The darkorange module was identified as a significantly associated mediator of the relationship between genetic background and tau seeding in high-dimensional mediation analysis (α = 0.0833, β = 35.7258, P = 0.0349).
“The darkorange module was identified as a significantly associated mediator (α = 0.0833, β = 35.7258, P = 0.0349).”
Quote in the paperSubstantial claim - Findingown data
Global significance score shows several pathways that were similarly modulated in PWK and CAST mice.
“Global significance score shows several pathways that were similarly modulated in PWK and CAST mice.”
Quote in the paperSubstantial claim - Findingown data
Normalized expression of the 29 genes of interest as measured by the nCounter platform identifies the largest effect in CAST and PWK mice compared to B6 and WSB mice.
“Strikingly, the normalized expression of these genes as measured by the nCounter platform identifies the largest effect in CAST and PWK mice compared to B6 and WSB mice (Fig. 8 C).”
Quote in the paperSubstantial claim - Findingown data
The eigenvalue of expression of genes in the darkorange module is increased in AAV-hTauP301L-injected mice relative to AAV-eGFP-injected controls.
“The eigenvalue of the expression of genes in the darkorange module is increased in AAV-hTauP301L–injected mice relative to AAV-eGFP–injected controls (Fig. 6 A).”
Quote in the paperSubstantial claim - Findingown data
There is an overlap of 310 genes shared between our viral model and either of the two selected transgenic tauopathy models.
“There is an overlap of 310 genes shared between our viral model and either of the two selected transgenic models (Fig. S5 A).”
Quote in the paperSubstantial claim - Findingown data
There are 21 homeostatic marker genes within the darkorange module (Fisher's exact test: P = 2.33 × 10−7).
“We found 21 homeostatic marker genes (Fisher’s exact test: P = 2.33 × 10−7) and 18 disease-associated marker genes (Fisher’s exact test: P = 2.31 × 10−5) within the darkorange module.”
Quote in the paperSubstantial claim - Findingown data
Key microglial genes (Trem2, Tyrobp, Tgfbr2) and complement cascade genes (C1qa, C1qb, Pros1) were affected by genetic background in both amyloid and tau studies.
“Interestingly, key microglial genes (Trem2, Tyrobp, Tgfbr2) and the complement cascade genes (C1qa, C1qb, Pros1) were affected by genetic background in both amyloid and tau studies (Fig. 5 C).”
Quote in the paperSubstantial claim - Findingown data
The cortex of wild-derived CAST and PWK mice permits significantly higher prion-like proteopathic seeding activity of tau compared to that of B6 controls.
“We report that the cortex of wild-derived CAST and PWK mice permits significantly higher prion-like proteopathic seeding activity of tau compared to that of B6 controls.”
Quote in the paperSubstantial claim - Findingown data
Darkorange is a significant mediator of the relationship between genetic background and tau seeding (joint significance via HIMA, P = 0.0349).
“Two steps of mediation analysis identified that darkorange is a significant mediator of the relationship between genetic background and tau seeding (joint significance calculated via HIMA, P = 0.0349).”
Quote in the paperSubstantial claim- The authors state this as an assumption: FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.
- Findingown data
KEGG enrichment of Signature C reveals microglia-related terms, calculated in gprofiler2 via Fisher's one-tailed test, with all terms P < 0.05.
“KEGG enrichment of Signature C reveals microglia-related terms calculated in gprofiler2 via Fisher’s one-tailed test (all terms P < 0.05).”
Quote in the paperSubstantial claim - Findingown data
Using a genotyping array, gigaMUGA, the three wild-derived strains contain many variants in the nominated targets from the AMP-AD database.
“Using a genotyping array, gigaMUGA, we report that these three wild-derived strains contain many variants in the nominated targets from the AMP-AD database (Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
PWK and CAST were the two genetic backgrounds susceptible to tau seeding.
“This subset of pathways was of interest to us since PWK and CAST were the two genetic backgrounds susceptible to tau seeding (Fig. 2 G).”
Quote in the paperSubstantial claim - Findingown data
KEGG enrichment of Signature C identified multiple immune responses.
“Multiple immune responses (Fig. 6 B) were identified using KEGG.”
Quote in the paperSubstantial claim - Findingown data
The expression score of each signature via PCA of raw reads demonstrated similar shifts in PWK and CAST, concordant with changes observed in tau seeding activity.
“The expression score of each signature via PCA of raw reads demonstrated similar shifts in PWK and CAST, which were concordant with the changes observed in tau seeding activity (Fig. 6 D).”
Quote in the paperSubstantial claim - Findingown data
The Innate Immune Response pathway was concordantly increased in PWK and CAST mice.
“The “Innate Immune Response” pathway was concordantly increased in PWK and CAST mice, while the “Microglia Function” pathway was decreased in both genetic backgrounds.”
Quote in the paperSubstantial claim - Findingown data
There is a core tau-responsive transcriptional signature that is not affected by genetic background (Signature A).
“First, a core tau-responsive transcriptional signature that is not affected by genetic background (Signature A).”
Quote in the paperSubstantial claim - Findingown data
WSB mice appear to have a unique downregulation in two genes involved in motor transport, Kif14 and Myl1.
“For example, WSB mice appear to have a unique downregulation in two genes involved in motor transport, Kif14 and Myl1 (Fig. 3 D).”
Quote in the paperNot a substantial claim - Findingown data
Analysis of the effect of genetic background on hTauP301L expressing mice further supported the role of Signature C (darkorange module) in the innate immune response and microglial function.
“Analysis of the effect of genetic background on hTauP301L expressing mice further supported the role of Signature C (darkorange module) in the innate immune response and microglial function (Fig. 8).”
Quote in the paperSubstantial claim - Findingown data
There is a unique transcriptional response to tau (Signature B).
“Second, a unique transcriptional response to tau that may indicate wild-derived mice should be used to study certain risk genes (Signature B).”
Quote in the paperSubstantial claim - Findingown data
21 of the 60 WGCNA modules were significantly associated with FRET+ seeding activity or wild-derived genetic background (Pearson's correlation, P < 0.05).
“21 of them were significantly associated with FRET+ seeding activity or wild-derived genetic background (Fig. S4 D; Pearson’s correlation, P < 0.05).”
Quote in the paperSubstantial claim - Findingown data
There is a tau seeding activity-associated transcriptional signature that implicates microglia (Signature C).
“Third, a tau seeding activity–associated transcriptional signature that implicates microglia (Signature C).”
Quote in the paperSubstantial claim - Findingown data
There is an increase in tau seeding activity in the cortex of CAST and PWK mice.
“We found an increase in tau seeding activity in the cortex of CAST and PWK mice (Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
We report a unique or "segregating" response to tau in wild-derived mice.
“We report a unique or “segregating” response to tau in wild-derived mice (Fig. 4).”
Quote in the paperSubstantial claim - Findingown data
Our network analysis identified a module of genes associated with the increase of tau seeding activity in CAST and PWK mice.
“Importantly, our network analysis identified a module of genes associated with this increase of tau seeding activity in CAST and PWK mice (Fig. 5).”
Quote in the paperSubstantial claim - Findingown data
The overlapping genes include Trem2, Tyrobp, Tgfbr2, and Cd68.
“These include Trem2, Tyrobp, Tgfbr2, and Cd68.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The viral approach preserves each genetic background without genetic drift or unwanted variants over a multiyear backcrossing experiment.
“we ensure that each genetic background is preserved without any possible genetic drift or the addition of unwanted variants over a multiyear backcrossing experiment.”
Quote in the paperSubstantial claim - Interpretationown data
Genetic variation across genetic backgrounds is the greatest driver of gene expression.
“These data suggest that genetic variation across genetic backgrounds is the greatest driver of gene expression.”
Quote in the paperSubstantial claim - Interpretationown data
The genetic heterogeneity across wild-derived mice exacerbates the prion-like action of tau in the brain cortex.
“Taken together, our data suggest that the genetic heterogeneity across wild-derived mice exacerbates the prion-like action of tau in the brain cortex.”
Quote in the paperSubstantial claim- The authors state this as an assumption: FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.
- Study design and conductown data
At least eight mice per group are needed to properly power the main study.
“This analysis indicates that at least eight mice per group are needed to properly power the main study.”
Quote in the paperSubstantial claim - Premisereasoning
Little is known about the effect of wild-derived mouse backgrounds on modeling tauopathy.
“Even though wild-derived backgrounds have been shown to have a large effect on modeling Aβ pathology, little is known about their effect on modeling tauopathy.”
Quote in the paperSubstantial claim - Interpretationown data
The core tau signature includes many targets that are already implicated in neurodegenerative diseases.
“These data demonstrate that the core tau signature includes many targets that are already implicated in neurodegenerative diseases.”
Quote in the paperNot a substantial claim - Interpretationown data
The genetic heterogeneity of the wild-derived mouse genetic backgrounds could modulate many genes of interest for the study of AD and related dementias.
“these data suggest that the genetic heterogeneity of the wild-derived mouse genetic backgrounds could modulate many genes of interest for the study of AD and related dementias.”
Quote in the paperSubstantial claim- Rests on an assumption: The AMP-AD nominated target genes are relevant to AD and related dementias.
- Interpretationown data
There exist some novel responses to tau present only in wild-derived mice.
“These data suggest that there exist some novel responses to tau present only in wild-derived mice.”
Quote in the paperSubstantial claim - Premisereasoning
The influence of genetic diversity on tau pathology and seeding has not been thoroughly investigated.
“Therefore, the influence of genetic diversity on tau pathology and seeding has not been thoroughly investigated.”
Quote in the paperSubstantial claim- Rests on an assumption: Most studies use the same monogenic mouse models, unlike genetically diverse human patients.
- Interpretationown data
A large part (2,467 genes) of the Signature A core tau signature is resistant to the variation between genetic backgrounds.
“These data suggest a large part (2,467 genes) of what we call the “Signature A: core tau signature” is resistant to the variation between genetic backgrounds.”
Quote in the paperSubstantial claim - Interpretationown data
The genetic variations across different mouse genetic backgrounds do not influence the ability to express tau using AAV-hTauP301L injection.
“These data suggest that the genetic variations across different mouse genetic backgrounds do not influence our ability to express tau using AAV-hTauP301L injection.”
Quote in the paperSubstantial claim - Interpretationown data
The immune system may be implicated in the increase in seed-competent tau observed in CAST and PWK mice.
“These data suggest that the immune system may be implicated in the increase in seed-competent tau observed in CAST and PWK mice.”
Quote in the paperSubstantial claim - Interpretationown data
The genetic backgrounds most susceptible to tau seeding had the most increase in markers of inflammation.
“Taken together, this suggests the genetic backgrounds that were most susceptible to tau seeding had the most increase in markers of inflammation.”
Quote in the paperSubstantial claim - Interpretationown data
Both pathways are sensitive to genetic context when modeling both hallmarks of AD.
“This finding suggests that both pathways are sensitive to genetic context when modeling both hallmarks of AD.”
Quote in the paperSubstantial claim - Interpretationown data
There is a core response to TauP301L/S expression that is shared between these three models.
“This example meta-analysis suggests that there is a core response to TauP301L/S expression that is shared between these three models.”
Quote in the paperSubstantial claim - Interpretationown data
Mouse genetic background is an important factor when studying immune responses to pathological tau species.
“Our data suggest that mouse genetic background is an important factor when studying immune responses to pathological tau species.”
Quote in the paperSubstantial claim - Interpretationown data
The upregulation of 28 darkorange module genes validates the involvement of these genes in the immune response to tau.
“We found that 28 out of 56 darkorange module genes on the mouse neuroinflammation panel were significantly upregulated in AAV-hTauP301L–injected mice versus AAV-eGFP–injected controls across all genetic backgrounds, validating the involvement of these darkorange module genes in the immune response to tau (Fig. 7, A–D).”
Quote in the paperSubstantial claim - Study design and conductnone given
In the cross-study comparison, it was not possible to match for sex, exact region, the promoter used by the model, or the genetic background of the mice in each study.
“However, it was not possible to match for sex, exact region, the promoter used by the model, or the genetic background of the mice in each study.”
Quote in the paperNot a substantial claim - Interpretationown data
The fundamental pathways involved in studying mouse models of dementia do not change across genetic backgrounds.
“This finding suggests that the fundamental pathways involved in studying mouse models of dementia do not change across genetic backgrounds.”
Quote in the paperSubstantial claim - Interpretationown data
Our enrichment analysis and comparison to previously published microglial contextual states suggest the importance of microglia in tau seeding.
“Our enrichment analysis and comparison to previously published microglial contextual states suggest the importance of microglia in tau seeding (Fig. 6).”
Quote in the paperSubstantial claim - Interpretationreasoning
This study provides compelling evidence that microglia within PWK and CAST mice contribute to an increased susceptibility to tau seeding.
“However, we believe that this study provides compelling evidence that microglia within PWK and CAST mice contribute to an increased susceptibility to tau seeding.”
Quote in the paperSubstantial claim - Interpretationown data
By combining unbiased whole transcriptomic analyses with targeted RNA probing, we have identified a subset of genes involved with tau seeding and increased inflammatory response.
“By combining unbiased whole transcriptomic analyses with targeted RNA probing, we have identified this subset of genes involved with tau seeding and increased inflammatory response.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 33
- May combine two claims. 23
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPreviously, genetic background has been shown to influence the amount of tau and the presence of at least one phospho-epitope in tau transgenic models.
“Previously, genetic background has been shown to influence the amount of tau and the presence of at least one phospho-epitope in tau transgenic models (Eskandari-Sedighi et al., 2017; Yanagisawa et al., 2021; Bailey et al., 2014).”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites Eskandari-Sedighi et al., 2017 source
The Results section, “Genetic profiles and tau expression in sublines of TgTauP301L mice” (page unavailable), reports no significant difference in human tau expression between the three genetic backgrounds. The Background says variation in tau deposition was shared between, and independent of, those backgrounds; the Results also report AT8-negative animals in all three. This paper therefore does not show the attributed genetic-background effect on tau amount or phospho-epitope presence. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites Yanagisawa et al., 2021 source
- cites Bailey et al., 2014 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOnos and colleagues observed an increase in neuroinflammation in the cortex and hippocampus of PWK mice.
“Notably, Onos and colleagues observed an increase in neuroinflammation in the cortex and hippocampus of PWK mice.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Onos et al., 2019 source
The Discussion describes substantial neuroinflammation in PWK.APP/PS1 mice, and the Results report that PWK had the greatest difference in myeloid-related gene expression between wild-type and APP/PS1 mice. The cited passages do not establish an increase specifically in both the cortex and hippocampus, and the claim omits the APP/PS1 genotype. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSeeding precedes tau pathogenesis and can even occur in brain regions where tau pathology does not usually present.
“Several studies have shown that seeding precedes tau pathogenesis and can even occur in brain regions where tau pathology does not usually present (DeVos et al., 2018; Kaufman et al., 2018; Stopschinski et al., 2021).”
Quote in the paperNot a substantial claim3 of 3 sources checkedClassified as probably not a substantial claim.
PremisecitationProteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner.
“Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Clavaguera et al., 2009 source
In the supplied passage labeled Abstract (page unavailable), the paper reports that insoluble tau induces aggregation and compares the spreading of tau pathology to prions. It does not establish that tau seeds enter cells: it presents entry as one possible mechanism and induction from outside cells as another. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites Frost et al., 2009 source
May combine two claims.
PremisecitationWild-derived mouse variants include over 5 million SNPs, 116 novel genes not present in B6, and between 250 and 400 large structural variants.
“These variants include over 5 million single nucleotide polymorphisms (SNPs; Onos et al., 2019), 116 novel genes not present in B6 (Lilue et al., 2018), and between 250 and 400 large structural variants (Yalcin et al., 2011).”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites Onos et al., 2019 source
- cites Lilue et al., 2018 source
The Results section, “Sequence assemblies and genome annotation” (page not available), identifies putative novel loci in wild-derived strains that do not overlap genes projected from the reference genome. It reports an average of 37 such genes per wild-derived strain, not the 116 novel genes attributed to Lilue et al. The SNP and structural-variant counts have separate citations and are not judged here. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Yalcin et al., 2011 source
The paper reports structural variants in four wild-derived inbred mouse strains, supporting that part of the cited clause. Its Abstract reports 0.71 million variants across all 17 strains, but our copy does not give a count of 250–400 large structural variants. The SNP and novel-gene figures have separate citations and are not assessed here. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHyperphosphorylated tau has been shown to cause neuronal cell death in humans.
“hyperphosphorylated tau has been shown to cause neuronal cell death (Lee et al., 2011)”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Lee et al., 2011 source
The introductory discussion says altered tau can cause neurodegeneration and that tau hyperphosphorylation is observed in human disease. But it says the contribution of phosphorylation to the onset of tau pathology in Alzheimer’s disease remains uncertain; it does not establish that hyperphosphorylated tau causes neuronal cell death in humans. The cited review supports a link between tau changes and neurodegeneration, not the claim’s specific causal conclusion. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCAST, PWK, and WSB mice contain millions of variants across the mouse genome.
“CAST, PWK, and WSB mice contain millions of variants across the mouse genome (Blake et al., 2021).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Blake et al., 2021 source
The section “Strain group comparisons for murine SNP data” (page not provided) says MGD contains almost 16 million SNPs from 88 mouse strains. It does not identify CAST, PWK, or WSB or establish that those particular strains each contain millions of variants. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSeveral studies have shown that transcriptional signatures can be used to investigate Aβ accumulation, region-specific expression of tau, and activated immune response.
“Several studies have shown that this hypothesis-generating, unbiased readout can be used to investigate Aβ accumulation (Sierksma et al., 2020), region-specific expression of tau (Castanho et al., 2020), and activated immune response (Kang et al., 2018).”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites Sierksma et al., 2020 source
- cites Castanho et al., 2020 source
The Introduction and Results describe transcriptional changes associated with tau pathology in the entorhinal cortex and compare findings with the hippocampus. They support using transcriptional signatures to investigate tau-related changes across brain regions, but do not establish region-specific expression of tau itself. The Aβ and immune-response clauses are attributed to other citations, not Castanho et al. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites Kang et al., 2018 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA previous study identified 11 mouse orthologs of genes within human AD GWAS loci that were co-expressed in mouse models of amyloid deposition.
“First, a previous study identified 11 mouse orthologs of genes within human AD genome-wide association study (GWAS) loci that were co-expressed in mouse models of amyloid deposition (Salih et al., 2019).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Salih et al., 2019 source
The Results section describes a co-expression network in amyloid-responsive mouse microglia containing seven established AD GWAS-associated genes and four newly proposed risk genes—11 genes in total (page unavailable). But it says the four new genes had not previously been reported as significantly associated with AD by traditional GWAS, so it does not support calling all 11 genes within established human AD GWAS loci. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationRecent studies in AD have shown that mouse genetic background can modulate Aβ accumulation, immune response, and tau propagation.
“Recent studies in AD have shown that mouse genetic background can modulate Aβ accumulation (Onos et al., 2019), immune response (Yang et al., 2021), and tau propagation (Dujardin et al., 2022).”
Quote in the paperSubstantial claim3 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevious studies of Trem2 on mixed background mice indicated an allele inherited by the SJL strain that unknowingly introduced a missense mutation.
“Previous studies of Trem2 on mixed background mice indicated an allele inherited by the SJL strain that unknowingly introduced a missense mutation (Yang et al., 2021).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Yang et al., 2021 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe gating strategy for singlet selection, CFP background removal, and FRET+ signal (BV510 channel) was performed as previously described.
“Our gating strategy for singlet selection, CFP background removal, and FRET+ signal (BV510 channel) were performed as previously described (Martinez et al., 2022).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Martinez et al., 2022 source
Classified as probably not a substantial claim.
Premisecitation11 mouse genes previously reported as orthologs of genes within human AD GWAS loci were selected.
“To characterize whether genes at known AD risk loci were responsible for the effect of genetic background, we selected 11 mouse genes previously reported as orthologs of genes within human AD GWAS loci (Salih et al., 2019).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Salih et al., 2019 source
The Results section (page unavailable) lists seven mouse genes whose human orthologues are established Alzheimer’s GWAS genes. It also describes four additional orthologues associated with Alzheimer’s disease in a gene-based analysis, but explicitly says those four had not previously been reported as significantly associated using traditional GWAS. The source therefore supports the orthologue relationship, not the characterization of all 11 as genes within previously known GWAS loci. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSeeding activity has been shown to identify the action of high molecular weight tau and to differentiate between specific conformers in 3R/4R tau diseases.
“As a pathological readout, seeding activity has been shown to identify the action of high molecular weight tau (Martinez et al., 2022) and even differentiate between specific conformers in 3R/4R tau diseases (Kraus et al., 2019).”
Quote in the paperNot a substantial claim2 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationIn previous studies, mice homozygous for the SJL allele were excluded from analysis.
“In previous studies, we have addressed this issue by excluding mice that are homozygous for the SJL allele from analysis (Karahan et al., 2021).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Karahan et al., 2021 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOnos and colleagues reported a list of 35 genes associated with a wild-derived specific response to amyloid transgene, identified as the 'light yellow' module via WGCNA module-trait analyses for genetic background and presence of the APP/PS1 transgene.
“First, Onos and colleagues reported a list of genes associated with a wild-derived specific response to amyloid transgene (Onos et al., 2019). This list of 35 genes was identified as the “light yellow” module via WGCNA module–trait analyses for genetic background and presence of the APP/PS1 transgene (Onos et al., 2019).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Onos et al., 2019 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevious research has demonstrated that interactors like Bassoon (Bsn) contribute to the ability of tau to seed and induce neurotoxicity.
“Our previous research has demonstrated that interactors like Bassoon (Bsn) contribute to the ability of tau to seed and induce neurotoxicity (Martinez et al., 2022).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Martinez et al., 2022 source
May combine two claims.
Findingown dataConsistent tau expression was observed in the cortex of AAV-hTauP301L-injected mice but not in AAV-eGFP-injected mice.
“Consistent tau expression was observed in the cortex of AAV-hTauP301L–injected mice (Fig. S2 A) but not in AAV-eGFP–injected mice (Fig. S2 B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data2,601 out of 5,792 variant calls were identical across CAST, PWK, and WSB mice, and there were strain-specific variants.
“While a large portion of these variant calls was identical across CAST, PWK, and WSB mice (2,601 out of 5,792), there were a number of strain-specific variants.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe darkorange module is the only one of these four modules to be positively correlated to FRET measurement (R2 = 0.54, P = 7 × 10−6) and showed a positive correlation to wild-derived background (R2 = 0.27, P = 0.03).
“The darkorange module is the only one of these four modules of interest to be positively correlated to FRET measurement (Fig. 5 A, R2 = 0.54, P = 7 × 10−6) and showed a positive correlation to wild-derived background (R2 = 0.27, P = 0.03).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA total of 4,784 DEGs were identified in B6; 5,260 in CAST; 4,657 in PWK; and 4,958 in WSB.
“We identified a total of 4,784 DEGs in B6; 5,260 DEGs in CAST; 4,657 DEGs in PWK, and 4,958 DEGs in WSB (DEG set size, Fig. 3 C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCyp3a43 contained the most genotyped variants with 563, only 163 of which were shared among all wild-derived mice.
“Cytochrome P450 3A43 (Cyp3a43; chr5: 137890932–146113285) contained the most genotyped variants with 563, only 163 of which were shared among all wild-derived mice.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWithin Inpp5d, there were five genotyped variants: one SNP shared by all three wild-derived mice, three SNPs shared only by CAST and PWK, and one SNP heterozygous in CAST and PWK but homozygous in WSB.
“within inositol polyphosphate-5-phosphatase D (Inpp5d;chr1:87620312–87720507), there were five genotyped variants (Fig. 1 B). One SNP was shared between all three wild-derived mice, three SNPs were shared only by CAST and PWK, and one SNP was heterozygous in CAST and PWK but homozygous in WSB (Table S1 C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere are 53 CAST-specific DEGs, 22 PWK-specific DEGs, and 25 WSB-specific DEGs.
“There are 53 CAST-specific DEGs, 22 PWK-specific DEGs, and 25 WSB-specific DEGs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSignatures A-C represent a core response to expressing AAV-hTauP301L (Signature A), a wild-derived specific response to AAV-hTauP301L expression (Signature B), and a tau seeding-associated module (Signature C).
“Signatures A–C of this study represent a core response to expressing AAV-hTauP301L (Signature A), wild-derived specific response to AAV-hTauP301L expression (Signature B), and a tau seeding–associated module (Signature C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe homeostatic microglial signature was significantly enriched (Fisher's exact test: P = 2.44 × 10−7) and showed the largest decrease in PWK mice injected with AAV-hTauP301L.
“The homeostatic microglial signature was significantly enriched (Fisher’s exact test: P = 2.44 × 10−7) and showed the largest decrease in PWK injected with AAV-hTauP301L.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe disease-associated microglial signature was significantly enriched (Fisher's exact test: P = 2.31 × 10−5) and shows the largest increase in PWK mice injected with AAV-hTauP301L.
“The disease-associated microglial signature was significantly enriched (Fisher’s exact test: P = 2.31 × 10−5) and shows the largest increase in PWK injected with AAV-hTauP301L.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe eigenvalue of genes in the darkorange module follows a similar pattern to tau seeding findings, with CAST and PWK mice showing increased expression relative to B6 and WSB.
“Furthermore, the eigenvalue of genes in this module follows a similar pattern to the tau seeding findings, with CAST and PWK mice showing increased expression relative to B6 and WSB.”
- Also stated in: § Signature C: Darkorange module implicates microglia in response to tau seeds · plain
“Differences observed in eigengene expression follow a similar pattern to tau seeding activity, with the largest increases observed in CAST and PWK mice injected with AAV-hTauP301L.”
Quote in the paperSubstantial claim- Also stated in: § Signature C: Darkorange module implicates microglia in response to tau seeds · plain
May combine two claims.
Findingown dataWe determined strain-specific genetic variants in wild-derived mouse genetic background using the Illumina Infinium platform and reported three transcriptional signatures identified via RNA-seq.
“In conclusion, we determined strain-specific genetic variants in wild-derived mouse genetic background using Illumina Infinium platform and reported three transcriptional signatures identified via RNA-seq.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataWGCNA identified a total of 60 modules.
“A total of 60 modules were identified (Fig. S4 C)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataUsing the marker selection approach, 170 DAM markers and 175 homeostatic markers were identified.
“Using this approach, we identified 170 DAM markers and 175 homeostatic markers.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHyperphosphorylated tau correlates with measures of cognitive decline in humans.
“to correlate with measures of cognitive decline (Arriagada et al., 1992) in humans.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Arriagada et al., 1992 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe significantly enriched KEGG pathways in Signature B, such as asthma and Staphylococcus aureus infection, are not obviously associated with the study of tauopathy.
“The significantly enriched KEGG pathways, such as asthma (KEGG:05310) and Staphylococcus aureus infection (KEGG:05150), are not obviously associated with the study of tauopathy.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningTrem2 is responsive to tau across mouse strains and is correlated to tau seeding observed in wild-derived mice.
“From this, we could conclude that Trem2 is responsive to tau across mouse strains and is correlated to tau seeding observed in wild-derived mice (Fig. 9 B).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe targeted transcriptomic approach identified two microglial pathways and replicated the bulk RNA-seq transcriptomics findings.
“In summary, these analyses of the targeted transcriptomic approach identified two microglial pathways and replicated our findings from bulk RNA-seq transcriptomics data.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningTrem2 response to tau is resilient to changes in genetic background and contributes to the formation of tau seeds.
“This suggests that Trem2 response to tau is resilient to changes in genetic background and contributes to the formation of tau seeds.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataNetwork analysis implicated microglia in the strain-specific seeding activity and replicated the findings using a targeted neuroinflammation panel.
“To better understand the mechanisms involved, we performed a network analysis that implicated microglia in this strain-specific seeding activity and replicated our findings using a targeted neuroinflammation panel.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThese wild-derived strains are an ideal resource for investigating the contribution of genetic variation to the study of AD and other tauopathies.
“Our data suggest that these wild-derived strains are an ideal resource for investigating the contribution of genetic variation to the study of AD and other tauopathies.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAAV9 has been shown to have high intracellular expression without an effect on mouse genetic background.
“We selected AAV9, which has been shown to have high intracellular expression without an effect on mouse genetic background (He et al., 2019).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites He et al., 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAfter outlier removal in WGCNA, 60 samples remained.
“After outlier removal in WGCNA, we were left with a total of 60 samples (Fig. S4 A).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningIncluding wild-derived mice may enhance the translatability to treating patients with different genetic backgrounds.
“Given that most therapeutic approaches are tested in mice before progressing to clinical trials, including wild-derived mice may enhance the translatability to treating patients with different genetic backgrounds.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe final sample size reached our requirement based on power analysis (B6 = 20, CAST = 20, PWK = 19, WSB = 24).
“The final sample size reached our requirement based on power analysis (B6 = 20, CAST = 20, PWK = 19, WSB = 24).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataA targeted assay (Nanostring Neuroinflammation Panel) was selected to independently validate the module discovered via network analysis of whole transcriptomic data.
“To independently validate the module discovered via network analysis of whole transcriptomic data (Figs. 5 and 6), we selected a targeted assay (Nanostring Neuroinflammation Panel) that provides a comprehensive survey of neuroinflammation (Fig. 7).”
Quote in the paperSubstantial claim- Rests on an assumption: The Nanostring Neuroinflammation Panel provides a comprehensive survey of neuroinflammation.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe gigaMUGA array contains 143,259 SNP and copy number variant markers that were selected to be informative in wild-derived mice and multiple Mus species.
“This array contains 143,259 SNP and copy number variants markers that were selected to be informative in wild-derived mice and multiple Mus species (Morgan et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Morgan et al., 2015
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenSample size was determined by the pilot study described in the Results section.
“Sample size was determined by the pilot study described in the Results section.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTotal brain lysate was transfected without normalizing to total tau levels.
“Total brain lysate was transfected without normalizing to total tau levels.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe data did not reach the suggested scale-free topology model fit cutoff of 0.9.
“Our data did not reach the suggested scale-free topology model fit cutoff of 0.9 (Fig. S4 B).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataOur data provide a resource for investigating tau in mouse models of AD and other tauopathies.
“Our data provide a resource for investigating tau in mouse models of AD and other tauopathies (Fig. 9 and Fig. S5).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe differential susceptibility of PWK and CAST mice to tauopathy implicates them as promising founder strains in future genetic mapping studies.
“Additionally, this differential susceptibility of PWK and CAST mice to tauopathy implicates them as promising founder strains in future genetic mapping studies.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationThe seeding assay was performed using TauRD P301S FRET Biosensor Cells.
“The seeding assay was performed using TauRD P301S FRET Biosensor Cells (Holmes et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Holmes et al., 2014 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll procedures and animal work were approved by the Indiana University School of Medicine Institutional Animal Care and Use Committee (Protocol 21149).
“All procedures and animal work were approved by the Indiana University School of Medicine Institutional Animal Care and Use Committee (Protocol 21149).”
Quote in the paperNot a substantial claim
The authors state this as an assumption.
FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.
“FRET+ signal is then measured by fluorescence-activated cell sorting (FACS) as a proxy for tau seeding activity.”
The paper relies on this without support.
Most studies use the same monogenic mouse models, unlike genetically diverse human patients.
“Unlike human patients who are genetically diverse, most studies use the same monogenic mouse models.”
The paper relies on this without support.
The AMP-AD nominated target genes are relevant to AD and related dementias.
“we focused on target genes nominated by the AMP-AD consortium.”
The paper relies on this without support.
No transcriptional information or mechanism of action has ever been proposed for how genetic background influences tau.
“However, no transcriptional information or mechanism of action has ever been proposed.”
The paper relies on this without support.
The Nanostring Neuroinflammation Panel provides a comprehensive survey of neuroinflammation.
“we selected a targeted assay (Nanostring Neuroinflammation Panel) that provides a comprehensive survey of neuroinflammation (Fig. 7).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
CAST seeding comparison is described as P < 0.001 despite an adjusted P of 0.046
MajorThe reported adjusted P value for B6 versus CAST is 0.046, contradicting the claim that both CAST and PWK differ from B6 at P < 0.001. CAST remains significant at the 0.05 threshold, but not at the stated threshold.
“CAST and PWK genetic background mice had a significant increase in tau seeding activity compared to B6 controls (P < 0.001).”
“B6-CAST p_adj = 0.046, B6-PWK p_adj = 1.12 × 10−4”
Main seeding-assay incubation is reported as both 24 and 48 hours
MinorFigure 2 describes transfecting biosensor cells with brain lysate for 24 hours, whereas the seeding-assay method says cells were harvested after an additional 48 hours.
“HEK-293T cells containing CFP- or YFP-conjugated tau are transfected with brain lysate from hTauP301L-injected mice for 24 h.”
“After an additional 48 h at 37°C, cells were harvested and FRET+ signal was measured via Flow Cytometry”
Variant totals differ between Figure 1 and the Results
MinorThe figure legend reports 5,810 variants in the 537 target genes, while the Results report 5,792 for the same target-gene set.
“Wild-derived mice contain 5,810 variants in the 537 nominated target genes from the AMP-AD consortium (accessed March 1, 2021).”
“In total, we found 5,792 variants in 537 nominated target genes (Table S1, A and B).”
Homeostatic microglial enrichment has two reported P values
MinorThe Figure 6 legend and Results give different P values for the homeostatic microglial marker enrichment.
“The homeostatic microglial signature was significantly enriched (Fisher’s exact test: P = 2.44 × 10−7)”
“We found 21 homeostatic marker genes (Fisher’s exact test: P = 2.33 × 10−7)”
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 3× · see citing works
“Raw read counts were analyzed for either differential expression analysis in DESeq2 (Love et al., 2014; v1.”
InfluentialWGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252 · see citing works
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219 · cited 1× · see citing works
“Reads were assigned to genomic features using featureCounts (Liao et al., 2014).”
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187 · cited 1× · see citing works
“The most widely used mouse strain in biomedical research, the C57BL/6J strain (herein referred to as B6), was established by the Jackson Laboratory in the 1920s and became the strain used to create the mouse reference genome (Mekada et al., 2009; Mouse Genome Sequencing et al., 2002).”
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · see citing works
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1× · see citing works
“The P301L mutation originally described in frontotemporal dementia patients (Hutton et al., 1998; Poorkaj et al., 1998) is often used to induce tau aggregate formation and study tau pathogenesis.”
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204 · cited 1× · see citing works
“Alzheimer ’ s disease (AD) is the most common cause of dementia and is characterized by the accumulation of amyloid plaques and neurofibrillary tangles mainly comprised of aggregated tau protein (Long and Holtzman, 2019).”
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 1× · see citing works
“For example, Trem2 , a known AD risk gene expressed in microglia (Krasemann et al., 2017; Sims et al., 2017), is present in Sig-natures A and C.”
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · cited 1× · see citing works
“Importantly, hyperphosphorylated tau has been shown to cause neuronal cell death (Lee et al., 2011) and to correlate with measures of cognitive decline (Arriagada et al., 1992) in humans.”
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · cited 2× · see citing works
“…to re-capitulate key aspects of human tauopathy including behavioral deficits (Lasagna-Reeves et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another (Dujardin et al., 2022;…”
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · cited 2× · see citing works
“Transgenic models of Tau P301L/S (Santacruz et al., 2005; Yoshiyama et al., 2007) and viral models of Tau P301L (Cook et al., 2015; Wegmann et al., 2017) are useful tools to study the progression of tau pathology and investigate factors that could lead to the risk of developing any tauopathy, including AD.”
Zhu, A., Ibrahim, J. G., & Love, M. I. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty895 · Cited by 2,012 · cited 1× · see citing works
“Up-and downregulated genes were defined using a significance cutoff of 0.05 (Benjamini Hochberg adjusted P values) and a 1.5-fold change (after apeglm effect size shrinkage [Zhu et al., 2019]).”
InfluentialMicroglia states and nomenclature: A field at its crossroads
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.020 · Cited by 1,973 · cited 2× · see citing works
“In light of the increasing effort to identify disease-and context-specific glial states (Keren-Shaul et al., 2017; Paolicelli et al., 2022; Ezerskiy et al., 2022), single-cell RNA-seq will be necessary to better understand which microglia cell types are involved in this phenotype.”
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803 · see citing works
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427 · cited 1× · see citing works
“…et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another (Dujardin et al., 2022; Rauch et al., 2020; Wegmann et al., 2017; de Calignon et al., 2012; Woerman et al., 2017).”
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374 · see citing works
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · cited 1× · see citing works
“Human genetic studies have identified variants that implicate several risk genes that influence AD pathogenesis (Karch and Goate, 2015).”
Breeding of a Non-Obese, Diabetic Strain of Mice
Makino, S., Kunimoto, K., MURAOKA, Y., Mizushima, Y., Katagiri, K., & Tochino, Y. (1980) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim1978.29.1_1 · Cited by 1,253 · cited 1× · see citing works
“For example, decreases in pancreatic insulin at 12 wk of age in the NOD/ShiLtJ mouse model established this strain as the leading model for research in type 1 diabetes (Makino et al., 1980).”
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252 · cited 1× · see citing works
“Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
Li, Q., Cheng, Z., Zhou, L., Darmanis, S., Neff, N. F., Okamoto, J., Gulati, G., Bennett, M. L., Sun, L. O., Clarke, L. E., et al. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.006 · Cited by 1,129 · see citing works
ARUK Consortium, Sims, R., GERAD/PERADES, C., van der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3916 · Cited by 1,126 · cited 1× · see citing works
“For example, Trem2 , a known AD risk gene expressed in microglia (Krasemann et al., 2017; Sims et al., 2017), is present in Sig-natures A and C.”
The Collaborative Cross, a community resource for the genetic analysis of complex traits
Churchill, G. A., Bogue, M. A., Paigen, B. J., Paigen, K., Pan, H.-J., Svenson, K. L., Airey, D. C., Allayee, H., Angel, J. M., Attie, A., et al. (2004) · Nature Genetics · doi:10.1038/ng1104-1133 · Cited by 1,114 · cited 2× · see citing works
“These eight founders were selected as they could be bred together to contain segregating variants every 100 – 200 base pairs (Churchill et al., 2004).”
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113 · cited 1× · see citing works
“There are a number of promising therapeutic approaches that target tau (Congdon and Sigurdsson, 2018).”
Proteopathic tau seeding predicts tauopathy in vivo
Holmes, B. B., Furman, J. L., Mahan, T. E., Yamasaki, T. R., Mirbaha, H., Eades, W. C., Belaygorod, L., Cairns, N. J., Holtzman, D. M., & Diamond, M. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411649111 · Cited by 696 · cited 2× · see citing works
“The seeding assay was performed using TauRD P301S FRET Biosensor Cells (Holmes et al., 2014).”
Protein transmission in neurodegenerative disease
Peng, C., Trojanowski, J. Q., & Lee, V. M.-Y. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0333-7 · Cited by 625 · see citing works
Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
Efthymiou, A. G., & Goate, A. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0184-x · Cited by 562 · see citing works
LRP1 is a master regulator of tau uptake and spread
Rauch, J. N., Luna, G., Guzman, E., Audouard, M., Challis, C., Sibih, Y. E., Leshuk, C., Hernandez, I., Wegmann, S., Hyman, B. T., et al. (2020) · Nature · doi:10.1038/s41586-020-2156-5 · Cited by 541 · cited 1× · see citing works
“…et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another (Dujardin et al., 2022; Rauch et al., 2020; Wegmann et al., 2017; de Calignon et al., 2012; Woerman et al., 2017).”
Litvinchuk, A., Wan, Y.-W., Swartzlander, D. B., Chen, F., Cole, A., Propson, N. E., Wang, Q., Zhang, B., Liu, Z., & Zheng, H. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.031 · Cited by 523 · see citing works
A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains
Simon, M. M., Greenaway, S., White, J. K., Fuchs, H., Gailus-Durner, V., Wells, S., Sorg, T., Wong, K., Bedu, E., Cartwright, E. J., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-7-r82 · Cited by 507 · cited 1× · see citing works
“While one goal of sustaining a single inbred line is to limit interlaboratory artifacts, research on B6 mice reveals that genetic drift and mixed background breeding have introduced a number of variants since the first draft of the mouse reference genome (Sarsani et al., 2019; Simon et al., 2013).”
A new set of BXD recombinant inbred lines from advanced intercross populations in mice
Peirce, J. L., Lu, L., Gu, J., Silver, L. M., & Williams, R. W. (2004) · BMC Genetics · doi:10.1186/1471-2156-5-7 · Cited by 484 · cited 1× · see citing works
“Another key strategy in harnessing mouse genetic diversity is to breed together different mouse strains to create multiparent panels for genetic mapping (Churchill et al., 2004, 2012; Peirce et al., 2004).”
Subspecific origin and haplotype diversity in the laboratory mouse
Yang, H., Wang, J., Didion, J. P., Buus, R. J., Bell, T. A., Welsh, C. E., Bonhomme, F., Yu, A. H.-T., Nachman, M. W., Piálek, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.847 · Cited by 459 · see citing works
The diversity outbred mouse population
Churchill, G. A., Gatti, D. M., Munger, S. C., & Svenson, K. L. (2012) · Mammalian Genome · doi:10.1007/s00335-012-9414-2 · Cited by 458 · cited 1× · see citing works
“The founder strains of the Jackson Laboratory ’ s multiparent panels, the Diversity Outbred and Collaborative Cross mice, include five classically inbred and three wild-derived mouse strains (Churchill et al., 2012).”
Mouse genome database (MGD): Knowledgebase for mouse-human comparative biology
Blake, J. A., Baldarelli, R., Kadin, J. A., Richardson, J. E., Smith, C. L., Bult, C. J., the Mouse Genome Database Group, Anagnostopoulos, A. V., Beal, J. S., Bello, S. M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1083 · Cited by 422 · cited 4× · see citing works
“More information about all variants in these wild-derived mice is available on the Mouse Genome Database (http:// www.informatics.jax.org).”
InfluentialGenetic Differences among C57BL/6 Substrains
Mekada, K., Abe, K., MURAKAMI, A., Satoe, N., Nakata, H., Moriwaki, K., Obata, Y., & Yoshiki, A. (2009) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.58.141 · Cited by 352 · cited 1× · see citing works
“The most widely used mouse strain in biomedical research, the C57BL/6J strain (herein referred to as B6), was established by the Jackson Laboratory in the 1920s and became the strain used to create the mouse reference genome (Mekada et al., 2009; Mouse Genome Sequencing et al., 2002).”
Sequence-based characterization of structural variation in the mouse genome
Yalcin, B., Wong, K., Agam, A., Goodson, M., Keane, T. M., Gan, X., Nellåker, C., Goodstadt, L., Nicod, J., Bhomra, A., et al. (2011) · Nature · doi:10.1038/nature10432 · Cited by 301 · cited 1× · see citing works
“These variants include over 5 million single nucleotide polymorphisms (SNPs; Onos et al., 2019), 116 novel genes not present in B6 (Lilue et al., 2018), and between 250 and 400 large structural variants (Yalcin et al., 2011).”
Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology
Sierksma, A., Lu, A., Mancuso, R., Fattorelli, N., Thrupp, N., Salta, E., Zoco, J., Blum, D., Buée, L., De Strooper, B., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910606 · Cited by 291 · see citing works
Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer’s Disease Brain
DeVos, S. L., Corjuc, B. T., Oakley, D. H., Nobuhara, C. K., Bannon, R. N., Chase, A., Commins, C., Gonzalez, J. A., Dooley, P. M., Frosch, M. P., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00267 · Cited by 285 · cited 1× · see citing works
“Several studies have shown that seeding precedes tau pathogenesis and can even occur in brain regions where tau pathology does not usually present (DeVos et al., 2018; Kaufman et al., 2018; Stopschinski et al., 2021).”
Lilue, J., Doran, A. G., Fiddes, I. T., Abrudan, M., Armstrong, J., Bennett, R., Chow, W., Collins, J., Collins, S., Czechanski, A., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0223-8 · Cited by 267 · cited 3× · see citing works
“These variants include over 5 million single nucleotide polymorphisms (SNPs; Onos et al., 2019), 116 novel genes not present in B6 (Lilue et al., 2018), and between 250 and 400 large structural variants (Yalcin et al., 2011).”
Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau
Kang, S. S., Ebbert, M. T. W., Baker, K. E., Cook, C., Wang, X., Sens, J. P., Kocher, J.-P., Petrucelli, L., & Fryer, J. D. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180653 · Cited by 260 · cited 1× · see citing works
“Several studies have shown that this hypothesis-generating, unbiased readout can be used to investigate A β accumulation (Sierksma et al., 2020), region-specific expression of tau (Castanho et al., 2020), and activated immune response (Kang et al., 2018).”
Kaufman, S. K., Del Tredici, K., Thomas, T. L., Braak, H., & Diamond, M. I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1855-6 · Cited by 259 · cited 1× · see citing works
“Several studies have shown that seeding precedes tau pathogenesis and can even occur in brain regions where tau pathology does not usually present (DeVos et al., 2018; Kaufman et al., 2018; Stopschinski et al., 2021).”
Kim, J., Grunke, S. D., Levites, Y., Golde, T. E., & Jankowsky, J. L. (2014) · Journal of Visualized Experiments · doi:10.3791/51863 · Cited by 250 · cited 1× · see citing works
“A full protocol for this approach was previously published (Kim et al., 2014; Passini et al., 2003).”
Self-citationThe Mouse Universal Genotyping Array: From Substrains to Subspecies
Morgan, A. P., Fu, C.-P., Kao, C.-Y., Welsh, C. E., Didion, J. P., Yadgary, L., Hyacinth, L., Ferris, M. T., Bell, T. A., Miller, D. R., et al. (2016) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.115.022087 · Cited by 214 · cited 1× · see citing works
“In argyle (Morgan, 2015), variants were recoded and filtered based on the position of the AMP-AD nominated target genes (accessed March 1, 2021).”
Estimating and testing high-dimensional mediation effects in epigenetic studies
Zhang, H., Zheng, Y., Zhang, Z., Gao, T., Joyce, B. T., Yoon, G., Zhang, W., Schwartz, J. D., Just, A. C., Colicino, E., et al. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw351 · Cited by 214 · cited 2× · see citing works
“First, high-dimensional mediation analysis (Zhang et al., 2016) was performed using R Package for High-Dimensional Mediation Analysis (http://github.com/dclarkboucher/hdmed; Clark-Boucher et al., 2023 Preprint ).”
Passini, M. A., Watson, D. J., Vite, C. H., Landsburg, D. J., Feigenbaum, A. L., & Wolfe, J. H. N. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.7034-7040.2003 · Cited by 213 · cited 1× · see citing works
“A full protocol for this approach was previously published (Kim et al., 2014; Passini et al., 2003).”
Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model
Lasagna‐Reeves, C. A., de Haro, M., Hao, S., Park, J., Rousseaux, M. W. C., Al‐Ramahi, I., Jafar‐Nejad, P., Vilanova-Velez, L., See, L., Maio, A. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.022 · Cited by 156 · cited 1× · see citing works
“These models have been shown to re-capitulate key aspects of human tauopathy including behavioral deficits (Lasagna-Reeves et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another…”
Self-citationSeeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
Kraus, A., Saijo, E., Metrick, M. A., Newell, K., Sigurdson, C. J., Zanusso, G., Ghetti, B., & Caughey, B. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1947-3 · Cited by 143 · cited 1× · see citing works
“As a pathological readout, seeding activity has been shown to identify the action of high molecular weight tau (Martinez et al., 2022) and even differentiate between specific conformers in 3R/4R tau diseases (Kraus et al., 2019).”
Microglial Malfunction: The Third Rail in the Development of Alzheimer's Disease
Mhatre, S. D., Tsai, C. A., Rubin, A. J., James, M. L., & Andreasson, K. I. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.006 · Cited by 134 · cited 1× · see citing works
“This is especially interesting given the important role of neuroinflammation in A β accumulation in AD (Efthymiou and Goate, 2017; Karahan et al., 2021; Mhatre et al., 2015; Schoch et al., 2021).”
Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets
Lee, V. M.-Y., Brunden, K. R., Hutton, M., & Trojanowski, J. Q. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006437 · Cited by 122 · see citing works
BRI2 (ITM2b) Inhibits A Deposition In Vivo
Kim, J., Miller, V. M., Levites, Y., West, K. J., Zwizinski, C. W., Moore, B. D., Troendle, F. J., Bann, M., Verbeeck, C., Price, R. W., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0891-08.2008 · Cited by 113 · cited 1× · see citing works
“We used an AAV-mediated gene expression model, as described before (Carlomagno et al., 2019; Cook et al., 2015; Kim et al., 2008).”
Self-citationGenetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk
Salih, D. A., Bayram, S., Guelfi, S., Reynolds, R. H., Shoai, M., Ryten, M., Brenton, J. W., Zhang, D., Matarin, M., Botia, J. A., et al. (2019) · Brain Communications · doi:10.1093/braincomms/fcz022 · Cited by 110 · see citing works
Enhancing face validity of mouse models of Alzheimer’s disease with natural genetic variation
Onos, K. D., Uyar, A., Keezer, K. J., Jackson, H. M., Preuss, C., Acklin, C. J., O’Rourke, R., Buchanan, R., Cossette, T. L., Sukoff Rizzo, S. J., et al. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008155 · Cited by 93 · cited 9× · see citing works
“…evidence, while Trem2 is differentially expressed in response to tau across all mouse strains, there is a possibility that it is involved in a CAST-or PWK-specific reaction to tau seeds. wild-derived mouse strains to a previous study of amyloid response in wild-derived strains (Onos et al., 2019).”
InfluentialCook, C., Kang, S. S., Carlomagno, Y., Lin, W.-L., Yue, M., Kurti, A., Shinohara, M., Jansen-West, K., Perkerson, E., Castanedes-Casey, M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv336 · Cited by 82 · cited 4× · see citing works
“We used an AAV-mediated gene expression model, as described before (Carlomagno et al., 2019; Cook et al., 2015; Kim et al., 2008).”
InfluentialSchoch, K. M., Ezerskiy, L. A., Morhaus, M. M., Bannon, R. N., Sauerbeck, A. D., Shabsovich, M., Jafar-nejad, P., Rigo, F., & Miller, T. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100356118 · Cited by 78 · cited 1× · see citing works
“This is especially interesting given the important role of neuroinflammation in A β accumulation in AD (Efthymiou and Goate, 2017; Karahan et al., 2021; Mhatre et al., 2015; Schoch et al., 2021).”
Yang, H. S., Onos, K. D., Choi, K., Keezer, K. J., Skelly, D. A., Carter, G. W., & Howell, G. R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108739 · Cited by 69 · cited 4× · see citing works
“Single-cell RNA sequencing (RNA-seq) of sorted microglia further demonstrated that the responses of immune cell subtypes, namely homeostatic microglia and disease-associated microglia (DAMs), are determined by wild-derived genetic backgrounds (Yang et al., 2021).”
InfluentialBassoon contributes to tau-seed propagation and neurotoxicity
Martinez, P., Patel, H., You, Y., Jury, N., Perkins, A., Lee-Gosselin, A., Taylor, X., You, Y., Viana Di Prisco, G., Huang, X., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01191-6 · Cited by 68 · cited 5× · see citing works
“…behavioral deficits (Lasagna-Reeves et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another (Dujardin et al., 2022; Rauch et al., 2020; Wegmann et al., 2017; de Calignon et…”
InfluentialSelf-citationThe Genome of C57BL/6J “Eve”, the Mother of the Laboratory Mouse Genome Reference Strain
Sarsani, V., Raghupathy, N., Fiddes, I. T., Armstrong, J. C., Thibaud‐Nissen, F., Zinder, O. J., Bolisetty, M. T., Howe, K., Hinerfeld, D., Ruan, X., et al. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400071 · Cited by 64 · cited 1× · see citing works
“While one goal of sustaining a single inbred line is to limit interlaboratory artifacts, research on B6 mice reveals that genetic drift and mixed background breeding have introduced a number of variants since the first draft of the mouse reference genome (Sarsani et al., 2019; Simon et al., 2013).”
Transcriptional signatures of tau and amyloid neuropathology
Castanho, I., Murray, T. K., Hannon, E., Jeffries, A., Walker, E., Laing, E., Baulf, H., Harvey, J., Bradshaw, L., Randall, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.063 · Cited by 62 · see citing works
Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia
Cook, C. N., Dunmore, J. H., Murray, M. E., Scheffel, K., Shukoor, N., Tong, J., Castanedes‐Casey, M., Phillips, V. R., Rousseau, L., Penuliar, M. S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.023 · Cited by 59 · cited 1× · see citing works
“These models have been shown to re-capitulate key aspects of human tauopathy including behavioral deficits (Lasagna-Reeves et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another…”
Karahan, H., Smith, D. C., Kim, B., Dabin, L. C., Al-Amin, M. M., Wijeratne, H. R. S., Pennington, T., Viana di Prisco, G., McCord, B., Lin, P. B.-C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3954 · Cited by 53 · cited 2× · see citing works
“In previous studies, we have addressed this issue by excluding mice that are homozygous for the SJL allele from analysis (Karahan et al., 2021).”
Self-citationargyle: An R Package for Analysis of Illumina Genotyping Arrays
Morgan, A. P. (2015) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.023739 · Cited by 45 · cited 4× · see citing works
“To identify genetic variants in our mice, we used the Illumina Infinium platform, containing 143,259 probes, designed specifically for wild-derived mice and other founders of the Diversity Outbred mouse model (Morgan et al., 2015).”
InfluentialBengoa‐Vergniory, N., Velentza‐Almpani, E., Silva, A. M., Scott, C., Vargas‐Caballero, M., Sastre, M., Wade‐Martins, R., & Alegre‐Abarrategui, J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01117-y · Cited by 45 · see citing works
Kinetics of human mutant tau prion formation in the brains of 2 transgenic mouse lines
Woerman, A. L., Patel, S., Kazmi, S. A., Oehler, A., Freyman, Y., Espiritu, L., Cotter, R., Castaneda, J. A., Olson, S. H., & Prusiner, S. B. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2822 · Cited by 44 · cited 1× · see citing works
“…et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another (Dujardin et al., 2022; Rauch et al., 2020; Wegmann et al., 2017; de Calignon et al., 2012; Woerman et al., 2017).”
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction
Ezerskiy, L. A., Schoch, K. M., Sato, C., Beltcheva, M., Horie, K., Rigo, F., Martynowicz, R., Karch, C. M. M., Bateman, R. J., & Miller, T. M. (2021) · JCI Insight · doi:10.1172/jci.insight.152012 · Cited by 44 · cited 1× · see citing works
“In light of the increasing effort to identify disease-and context-specific glial states (Keren-Shaul et al., 2017; Paolicelli et al., 2022; Ezerskiy et al., 2022), single-cell RNA-seq will be necessary to better understand which microglia cell types are involved in this phenotype.”
Seed-competent tau monomer initiates pathology in a tauopathy mouse model
Mirbaha, H., Chen, D., Mullapudi, V., Terpack, S. J., White, C. L., Joachimiak, Ł. A., & Diamond, M. I. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102163 · Cited by 39 · cited 1× · see citing works
“These seeding activity assays have assisted in the discovery of novel tau interactors and been used to investigate phosphorylation patterns associated with tau progression (Martinez et al., 2022; Mirbaha et al., 2022).”
Clark‐Boucher, D., Zhou, X., Du, J., Liu, Y., Needham, B. L., Smith, J. A., & Mukherjee, B. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1011022 · Cited by 38 · see citing works
Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model
Bailey, R. M., Howard, J., Knight, J., Sahara, N., Dickson, D. W., & Lewis, J. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-8 · Cited by 33 · see citing works
A Bayesian model selection approach to mediation analysis
Crouse, W. L., Keele, G. R., Gastonguay, M. S., Churchill, G. A., & Valdar, W. S. J. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010184 · Cited by 31 · cited 2× · see citing works
“Second, we performed a Bayesian module selection approach to test whether darkorange was acting as a complete or partial mediator (Crouse et al., 2022).”
Mouse Phenome Database Team, Kollmus, H., Fuchs, H., Lengger, C., Haselimashhadi, H., Bogue, M. A., Östereicher, M. A., Horsch, M., Adler, T., Aguilar‐Pimentel, J. A., et al. (2020) · Mammalian Genome · doi:10.1007/s00335-020-09827-3 · Cited by 30 · cited 1× · see citing works
“Deep characterization of these wild-derived mice has uncovered genetic (Morgan et al., 2015), behavioral (Kollmus et al., 2020), and immune (Lilue et al., 2018) differences that are improving our knowledge of mouse genetics.”
Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses
Wegmann, S., Bennett, R. E., Amaral, A. C. S., & Hyman, B. T. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.014 · Cited by 26 · cited 2× · see citing works
“…et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another (Dujardin et al., 2022; Rauch et al., 2020; Wegmann et al., 2017; de Calignon et al., 2012; Woerman et al., 2017).”
Anatomic survey of seeding in Alzheimer’s disease brains reveals unexpected patterns
Stopschinski, B. E., Del Tredici, K., Estill-Terpack, S.-J., Ghebremedhin, E., Yu, F. F., Braak, H., & Diamond, M. I. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01255-x · Cited by 26 · see citing works
The Influence of Murine Genetic Background in Adeno-Associated Virus Transduction of the Mouse Brain
He, T., Itano, M. S., Earley, L. F., Hall, N. E., Riddick, N. V., Samulski, R. J., & Li, C. (2019) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2019.030 · Cited by 25 · cited 1× · see citing works
“We selected AAV9, which has been shown to have high intracellular expression without an effect on mouse genetic background (He et al., 2019).”
The Riken mouse genome encyclopedia project
Hayashizaki, Y. (2003) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2003.09.018 · Cited by 23 · cited 1× · see citing works
“From these lists of genes, we then removed any ribosomal genes and any unannotated genes from either the Riken mouse genome encyclopedia (Hayashizaki, 2003) or Mouse Genome Informatics (Blake et al., 2021; prefixes “ Gm-” or suf-fixes “ -Rik ” ).”
Eskandari-Sedighi, G., Daude, N., Gapeshina, H., Sanders, D. W., Kamali-Jamil, R., Yang, J., Shi, B., Wille, H., Ghetti, B., Diamond, M. I., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0215-7 · Cited by 22 · see citing works
A portal to visualize transcriptome profiles in mouse models of neurological disorders
Al-Ouran, R., Wan, Y.-W., Mangleburg, C. G., Lee, T. V., Allison, K., Shulman, J. M., & Liu, Z. (2019) · Genes · doi:10.3390/genes10100759 · Cited by 19 · see citing works
Monzón-Sandoval, J., Burlacu, E., Agarwal, D., Handel, A. E., Wei, L., Davis, J., Cowley, S. A., Cader, M. Z., & Webber, C. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049349 · Cited by 18 · see citing works
Gan, K. J., Akram, A., Blasius, T. L., Ramser, E. M., Budaitis, B. G., Gabrych, D. R., Verhey, K. J., & Silverman, M. A. (2020) · eNeuro · doi:10.1523/eneuro.0176-20.2020 · Cited by 16 · cited 1× · see citing works
“For those studying the role of motor transport in AD (Gan et al., 2020), the WSB background may provide insights that would not be observed using B6 mice.”
Onos, K. D., Quinney, S. K., Jones, D. R., Masters, A. R., Pandey, R., Keezer, K. J., Biesdorf, C., Metzger, I. F., Meyers, J. A., Peters, J., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12329 · Cited by 16 · cited 1× · see citing works
“As preclinical studies continue to make direct comparisons between human and mouse transcriptomics (Monzón-Sandoval et al., 2022; Onos et al., 2022), our list of core genes can be interpreted as robust tau-responsive genes for future study.”
Self-citationTau propagation is dependent on the genetic background of mouse strains
Dujardin, S., Fernandes, A., Bannon, R., Commins, C., De Los Santos, M., Kamath, T. V., Hayashi, M., & Hyman, B. T. (2022) · Brain Communications · doi:10.1093/braincomms/fcac048 · Cited by 11 · cited 2× · see citing works
“…et al., 2016; Cook et al., 2014), neuro-inflammation (Yoshiyama et al., 2007), prion-like proteopathic seeding (Martinez et al., 2022), and propagation from one cell to another (Dujardin et al., 2022; Rauch et al., 2020; Wegmann et al., 2017; de Calignon et al., 2012; Woerman et al., 2017).”
Carlomagno, Y., Chung, D. C., Yue, M., Kurti, A., Avendano, N. M., Castanedes‐Casey, M., Hinkle, K. M., Jansen‐West, K. R., Daughrity, L. M., Tong, J., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0661-2 · Cited by 10 · cited 2× · see citing works
“We used an AAV-mediated gene expression model, as described before (Carlomagno et al., 2019; Cook et al., 2015; Kim et al., 2008).”
Clark-Boucher, D., Zhou, X., Du, J., et al. (2023) · doi:10.1101/2023.02.10.23285764 · Cited by 10
Tau seeding activity in various regions of down syndrome brain assessed by two novel assays
Jin, N., Gu, J., Wu, R., Chu, D., Tung, Y. C., Węgiel, J., Wısnıewskı, T., Gong, C., Iqbal, K., & Liu, F. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01436-2 · Cited by 8 · cited 1× · see citing works
“Several in vitro models have been developed that can measure tau seeding activity from human patients or mouse models of tauopathy (Bengoa-Vergniory et al., 2021; Holmes et al., 2014; Jin et al., 2022).”
Differential accumulation of tau pathology between reciprocal F1 hybrids of rTg4510 mice
Yanagisawa, D., Hamezah, H. S., Pahrudin Arrozi, A., & Tooyama, I. (2021) · Scientific Reports · doi:10.1038/s41598-021-89142-2 · Cited by 7 · cited 1× · see citing works
“Previously, genetic background has been shown to influence the amount of tau and the presence of at least one phospho-epitope in tau transgenic models (Eskandari-Sedighi et al., 2017; Yanagisawa et al., 2021; Bailey et al., 2014).”
Flagged first, then by citations
Cited by
Sorted by citations
Sasner, M., Onos, K. D., Territo, P. R., & Rizzo, S. J. S. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13742 · Cited by 2 · see citing works
“42,43 44–46 More specifically he provided insight into the prioritization of SHIP1 ( INPP5D ) as a target by the IU-Purdue TREAT-AD center and shared data for the biological hypothesis, SHIP1 ligand discovery approach, lead compound characterization, and translational PD studies being pursued.”
MethodPark, J. H., Kim, B., Al‐Amin, M. M., Tate, M. D., Sharify, A. D., John, S. K., Karahan, H., Lu, H., Dabin, L. C., & Kim, J. (2026) · Alzheimer's & Dementia · doi:10.1002/alz.71742
“25,26 Briefly, A β concentrations were measured in guanidine-soluble cortical fractions using the V-PLEX Plus A β Peptide Panel 1 (6E10) Kit (MSD; K15200E).”
Self-citationWyatt‐Johnson, S. K., Joshi, S., Blair, M., Desai, J. M., Haeryfar, S. M. M., Lasagna‐Reeves, C. A., & Brutkiewicz, R. R. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106969
Self-citation
- Authors
- Acri, D. J., You, Y., Tate, M. D., Karahan, H., Martinez, P., McCord, B., Sharify, A. D., John, S., Kim, B., Dabin, L. C., Philtjens, S., Wijeratne, H. R. S., McCray, T. J., Smith, D. C., Bissel, S. J., Lamb, B. T., Lasagna-Reeves, C. A., & Kim, J.
- Affiliations
- Indiana University Indianapolis (US)
- Indiana University 3 Department of Anatomy, Cell Biology and Physiology, , Indianapolis, IN, USA
- Stark Neurosciences Research Institute, Indiana University 1 , Indianapolis, IN, USA
- Corresponding author
- Kim, Jungsu
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2023-08-22
- Volume
- 220
- Issue
- 11
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC10443211
- OpenAlex
- W4386045870
- Semantic Scholar
- 1db8e37015babe0e8d5f976e81531f3740c891e9
- Cited by
- 3
- References
- 82
- Citations by year
- 2026: 2 · 2024: 1
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health (R01 AG077829, R01 AG071281, RF1 AG074543, R21 AG072738, T32AG071444, F31AG074673, F30AG079580, F31AG074628, T32DK064466)
- Indiana University
- School of Medicine, Indiana University
- Indiana Clinical Translational Sciences Institute
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau aggregation, tau seeding, Alzheimer's disease, genetic background, wild-derived mice, MAPT, transcriptome, microglia, gene modules, CAST/EiJ, C57BL/6J mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-17.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-17.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review